Effectiveness of Inactivated COVID-19 Vaccines against COVID-19 Caused by the SARS-CoV-2 Delta and Omicron Variants: A Retrospective Cohort Study
Open Access
Abstract
Background: Real-world evidence on the effectiveness of inactivated vaccines against the Delta and Omicron (BA.2.38) variants remains scarce. Methods: A retrospective cohort study was conducted to estimate the adjusted vaccine effectiveness (aVE) of one, two, and three doses of inactivated vaccines in attenuating pneumonia, severe COVID-19, and the duration of viral shedding in Delta and Omicron cases using modified Poisson and linear regression as appropriate. Results: A total of 561 COVID-19 cases were included (59.2% Delta and 40.8% Omicron). In total, 56.4% (184) of Delta and 12.0% (27) of Omicron cases had COVID-19 pneumonia. In the two-dose vaccinated population, 1.4% of Delta and 89.1% of Omicron cases were vaccinated for more than 6 months. In Delta cases, the two-dose aVE was 52% (95% confidence interval, 39–63%) against pneumonia and 61% (15%, 82%) against severe disease. Two-dose vaccination reduced the duration of viral shedding in Delta cases, but not in booster-vaccinated Omicron cases. In Omicron cases, three-dose aVE was 68% (18%, 88%) effective against pneumonia, while two-dose vaccination was insufficient for Omicron. E-values were calculated, and the E-values confirmed the robustness of our findings. Conclusions: In Delta cases, two-dose vaccination within 6 months reduced pneumonia, disease severity, and the duration of viral shedding. Booster vaccination provided a high level of protection against pneumonia with Omicron and should be prioritized.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFC0867400, 2020YFA0708001, 2021XK06, 2021XK49, 2021ZYLCYJ04-1, 2021ZYLCYJ04-2, 2021ZYLCYJ07-2)
- Collaborative innovation team project of Guangzhou University of Chinese Medicine (2022YFC0867400, 2020YFA0708001, 2021XK06, 2021XK49, 2021ZYLCYJ04-1, 2021ZYLCYJ04-2, 2021ZYLCYJ07-2)
- National Administration of Traditional Chinese Medicine (2022YFC0867400, 2020YFA0708001, 2021XK06, 2021XK49, 2021ZYLCYJ04-1, 2021ZYLCYJ04-2, 2021ZYLCYJ07-2)
This publication has 30 references indexed in Scilit:
- Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further researchVaccine, 2021
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in AdultsJAMA, 2021
- Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV StudySSRN Electronic Journal, 2021
- Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral InfectionsBiomedicines, 2021
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- Sensitivity Analysis in Observational Research: Introducing the E-ValueAnnals of Internal Medicine, 2017
- Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination statusHuman Vaccines & Immunotherapeutics, 2015
- Laboratory Characterization of Measles Virus Infection in Previously Vaccinated and Unvaccinated IndividualsThe Journal of Infectious Diseases, 2011
- A Modified Poisson Regression Approach to Prospective Studies with Binary DataAmerican Journal of Epidemiology, 2004
- Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical SeverityClinical Infectious Diseases, 2003